Target intelligence / Profile preview

Monocyte to macrophage differentiation-associated 2 (MMD2)

Target
MMD2
Molecular classification
Receptor (specifically, progestin and adipoQ receptor family), Seven-transmembrane domain protein (structurally similar to G protein-coupled receptors, though there is debate about canonical coupling), Membrane protein (localized to Golgi apparatus), Ras signaling modulator (functionally and structurally related to regulatory proteins in signal transduction)
01

Overview

Monocyte to macrophage differentiation-associated 2 (MMD2), also known as PAQR10, is a membrane protein of the progestin and adipoQ receptor family characterized by seven transmembrane domains and evolutionary conservation with hemolysin-like bacterial proteins. It is localized to the Golgi apparatus and acts as a modulator of Ras signaling, most notably stimulating ERK phosphorylation and the differentiation of cells such as PC12 in response to Ras pathway activation. Functional genomic studies implicate MMD2 in macrophage differentiation, immune system regulation, and disease susceptibility—particularly in chronic inflammatory conditions like Crohn's disease. Other members of the PAQR family are important in metabolic and sex steroid signaling, but MMD2/PAQR10 are distinctive for their role in Golgi-localized control of Ras activity. Research into therapeutic modulation of MMD2 is ongoing, with its function linked to pathways central to immunity, cell growth, and the development of malignancy.

Other names
PAQR10Monocyte to macrophage differentiation factor 2Progestin and adipoQ receptor family member 10Monocyte-to-macrophage differentiation-associated protein 2
02

Mechanism of action

Drugs would potentially act by modulating Ras signaling in the Golgi apparatus—either through interaction with MMD2/PAQR10’s seven-transmembrane domains or altering its interaction with Ras or RasGRP1.

03

Biological functions

Macrophage development and differentiationModulation of Ras signaling in the Golgi apparatusRegulation of ERK pathway activityCell growth control (studied as a growth suppressor in some species)Potential roles in metabolism and apoptosis (speculated due to PAQR family connections, but not directly confirmed for MMD2/PAQR10)
04

Disease associations

Inflammation (linked to innate immunity and Crohn’s disease susceptibility through macrophage regulation)Cancer (potential involvement via Ras/ERK pathway modulation)Muscular dystrophy (GeneCards reports association with Miyoshi Muscular Dystrophy 2/3, though this is less established in the literature)Other immune-related diseases (based on macrophage/innate immune dysregulation)
05

Safety considerations

Off-target effects from modulation of Ras signaling, which is broadly implicated in cell growth, proliferation, and differentiation (possible cancer risk, abnormal cell growth)Potential risk associated with broad manipulation of macrophage differentiation or immune cell function (immune dysregulation)No specific safety data for targeted MMD2 inhibition or activation are available.
06

Interacting drugs

None explicitly reported in the search results (there is currently no clinically approved drug targeting MMD2/PAQR10 directly; research is ongoing in the context of Ras pathway modulators.)
07

Biomarkers

Variants in MMD2 may be considered biomarkers for innate immunity status or disease susceptibility in chronic inflammation (such as Crohn’s disease)There are no well-established clinical biomarkers tied to drug efficacy or patient selection for this target at present.

Beyond the preview

Go deeper on Monocyte to macrophage differentiation-associated 2 (MMD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monocyte to macrophage differentiation-associated 2 (MMD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call